Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.19.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2019
Dec. 31, 2018
Current assets:    
Cash and cash equivalents $ 3,893,604 $ 4,273,012
Accrued interest receivable 4,161
Prepaid expenses and other current assets 57,070 61,433
Total current assets 3,954,835 4,334,445
Prepaid expense, less current portion 2,293
Total assets 3,954,835 4,336,738
Current liabilities:    
Accounts payable and accrued expenses 210,673 195,211
Research and development contract liabilities 34,139 15,704
Total current liabilities 244,812 210,915
Commitments and contingencies
Stockholders' equity:    
Preferred Stock, $0.0001 par value; authorized - 10,000,000 shares; issued and outstanding - 350,000 shares of Series A Convertible Preferred Stock, $10.00 per share stated value, $50.00 per share cash redemption value; aggregate cash redemption value - $17,500,000; liquidation preference based on assumed conversion into common shares - 4,375,000 shares 3,500,000 3,500,000
Common stock, $0.0001 par value; authorized - 100,000,000 shares; issued and outstanding - 67,045,814 shares 6,704 6,704
Additional paid-in capital 25,280,598 25,267,662
Accumulated deficit (25,077,279) (24,648,543)
Total stockholders' equity 3,710,023 4,125,823
Total liabilities and stockholders' equity $ 3,954,835 $ 4,336,738